Olivier Boillot
Overview
Explore the profile of Olivier Boillot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
1618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erard D, Steiner A, Boillot O, Thimonier E, Vallin M, Veyre F, et al.
Clin Transplant
. 2024 Nov;
38(11):e70014.
PMID: 39552184
Background: De novo malignancies are one of the leading causes of death after liver transplantation (LT), particularly in patients transplanted for alcohol-related liver disease (ALD). This retrospective study aimed to...
2.
Dumortier J, Boillot O
Transpl Immunol
. 2024 Feb;
83:102014.
PMID: 38395088
Background: After organ transplantation, strategies for simplifying the therapeutic regimen may improve adherence and prevent acute organ rejection and/or late graft loss. The present study aimed to evaluate the safety...
3.
Erard D, Villeret F, Chouik Y, Guillaud O, Scoazec J, Caussy C, et al.
Liver Int
. 2023 Nov;
44(2):422-432.
PMID: 38010979
Background & Aims: If alcohol-related liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are now the two main indications for liver transplantation (LT), it has been recognized that both...
4.
Boillot O, Guillaud O, Wischlen E, Ruiz M, Boucaud C, Rohmer B, et al.
Clin Res Hepatol Gastroenterol
. 2023 Oct;
47(9):102222.
PMID: 37783384
Background: The risk of early surgical complications of liver transplantation (LT) is higher in children when compared with adults. The aims of the present retrospective study from a single center...
5.
Daniel J, Dumortier J, Del Bello A, Gamon L, Molinari N, Faure S, et al.
JHEP Rep
. 2023 Sep;
5(10):100832.
PMID: 37681206
Background & Aims: Liver transplantation (LT) is a last resort treatment for patients at high risk of mortality from end-stage liver disease. Over the past years, alcohol-associated liver disease has...
6.
Dumortier J, Conti F, Hiriart J, Dharancy S, Duvoux C, Besch C, et al.
Liver Transpl
. 2023 Jun;
29(12):1313-1322.
PMID: 37367954
The deleterious effect of donor-specific anti-HLA antibodies (DSA) after liver transplantation (LT) has been increasingly recognized during the past decade. Antibody-mediated rejection (AMR) represents a rare but severe complication in...
7.
Wischlen E, Laverdure N, Erard D, Rohmer B, Boillot O, Dubois R, et al.
Clin Res Hepatol Gastroenterol
. 2023 May;
47(6):102139.
PMID: 37187258
Post-transplantation evolution of progressive familial intrahepatic cholestasis type 2 patients can be complicated by antibody-induced bile salt export pump deficiency (AIBD). There is no consensus on its management. We describe...
8.
Villeret F, Dharancy S, Erard D, Abergel A, Barbier L, Besch C, et al.
JHEP Rep
. 2023 Feb;
5(3):100668.
PMID: 36852108
Background & Aims: Liver transplantation (LT) is the only available treatment for end-stage non-alcoholic fatty liver disease (NAFLD) (related decompensated cirrhosis and/or hepatocellular carcinoma). The aim of our study was...
9.
Dumortier J, Guillaud O, Boillot O
Clin Res Hepatol Gastroenterol
. 2023 Jan;
47(3):102085.
PMID: 36652989
No abstract available.
10.
Wischlen E, Boillot O, Rivet C, Lachaux A, Bouvier R, Hervieu V, et al.
Clin Transplant
. 2022 Dec;
37(2):e14898.
PMID: 36585804
Background: The role of protocol liver biopsies (PLB) in the follow-up of pediatric liver transplant recipients remains questionable. This single-center retrospective study aimed to evaluate their clinical impact on the...